We are pleased to let you know that our EMPIRICAL abstract (see below) has been accepted for the Poster Walk.

Poster Walk

Title 30 – Suboptimal Lopinavir Exposure in Infants 1-12 Months on Rifampicin Treatment Receiving Double-Dosed or Semi-superboosted Lopinavir/Ritonavir; Results from the EMPIRICAL Trial.
Paper Number 30
Paper Status Poster Walk
Session Details Poster Walks
Wednesday, Jul 27, 2022
6:15 PM – 7:30 PM
Presenting Author Mr. Tom Jacobs
Affiliations: Clinical Pharmacy Department, Radboudumc, Nijmegen, The Netherlands



For More details please see the web